Clinical Trial Update: Intraarterial Infusion of Autologous Bone Marrow in Diabetic Patients With Chronic Ischemia of Lower Limbs (CLI) no Revascularization [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating intraarterial infusion of autologous bone marrow cells in diabetic patients with chronic limb ischemia without revascularization ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetic Foot

Drugs mentioned

• Autologous bone marrow cell infusion (bone marrow-derived autologous cells)

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Critical Limb Ischemia (CLI), Diabetic Foot | Phase 1, Phase 2 | Status: COMPLETED